Paper503223
Induction and kinetics of natural killer cells in humans following interferon therapy.
Huddlestone JR and 2 others. Nature, 1979. Cited by 156 papers, by iCite.
Cite this record
ConductScience Library. Induction and kinetics of natural killer cells in humans following interferon therapy. Papers, record 503223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/503223
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Immunity, Innate | Major topic |
| Interferons | Major topic |
| Killer Cells, Natural | Major topic |
| Humans | |
| Lymphoma |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41107895 | The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41107895 | PubMed |
| 31547251 | NK Cell Hyporesponsiveness: More Is Not Always Better. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31547251 | PubMed |
| 27010978 | A Computational Model of Inhibition of HIV-1 by Interferon-Alpha. | PLoS One | 2016 | https://conductscience.org/library/papers/27010978 | PubMed |
| 25469725 | Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo. | Clin Exp Immunol | 2015 | https://conductscience.org/library/papers/25469725 | PubMed |
| 24941370 | Natural killer activity: early days, advances, and seminal observations. | Crit Rev Oncog | 2014 | https://conductscience.org/library/papers/24941370 | PubMed |
| 6690072 | Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6690072 | PubMed |
| 6466539 | Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6466539 | PubMed |
| 6379511 | Clinical effect of interferon in malignant brain tumours. | Neurosurg Rev | 1984 | https://conductscience.org/library/papers/6379511 | PubMed |
| 6292259 | The biology of the human natural killer cell. | J Clin Immunol | 1982 | https://conductscience.org/library/papers/6292259 | PubMed |
| 6284642 | Natural cell-mediated cytotoxicity of bovine mononuclear cells against virus-infected cells. | Infect Immun | 1982 | https://conductscience.org/library/papers/6284642 | PubMed |
| 6251708 | Antibody-mediated destruction of virus-infected cells. | Adv Immunol | 1980 | https://conductscience.org/library/papers/6251708 | PubMed |
| 6237664 | In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6237664 | PubMed |
| 6203638 | Natural killer cells in human solid tumors. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6203638 | PubMed |
| 6180219 | Effect of human fibroblast interferon on natural killer cell activity: stimulation in vitro and inhibition in vivo. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6180219 | PubMed |
| 6178542 | Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6178542 | PubMed |
| 6178525 | Clinical and immunological studies of human fibroblast interferon. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6178525 | PubMed |
| 6177714 | Medullasin enhances human natural killer cell activity. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6177714 | PubMed |
| 6175462 | Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leucocytes. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6175462 | PubMed |
| 6174541 | Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/6174541 | PubMed |
| 6173188 | Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. | Drugs | 1982 | https://conductscience.org/library/papers/6173188 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/503223
GET https://conductscience.org/api/papers/v1/503223/cited_by?page=2